{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:55:19Z","timestamp":1789880119728,"version":"4.0.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/ajp.0b013e318287a32f","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T07:48:54Z","timestamp":1361951334000},"page":"134-142","source":"Crossref","is-referenced-by-count":39,"title":["NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-associated Distal Sensory Polyneuropathy"],"prefix":"10.1097","volume":"30","author":[{"given":"David M.","family":"Simpson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey K.","family":"Tobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertrui F.","family":"Vanhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210204","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1529-8027.2001.006001008.x","article-title":"Epidemiology and clinical features of HIV-1 associated neuropathies.","volume":"6","author":"Verma","year":"2001","journal-title":"J Peripher Nerv Syst"},{"key":"R3-6-20210204","first-page":"153","article-title":"Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.","volume":"9","author":"Simpson","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R8-6-20210204","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ncl.2008.04.001","article-title":"Diagnosis and management of HIV-associated neuropathy.","volume":"26","author":"Gonzalez-Duarte","year":"2008","journal-title":"Neurol Clin"},{"key":"R10-6-20210204","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0885-3924(00)00140-8","article-title":"Pain and pain treatment in AIDS patients: a longitudinal study.","volume":"19","author":"Frich","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"R14-6-20210204","first-page":"159","article-title":"Vanilloid (capsaicin) receptors and mechanisms.","volume":"51","author":"Szallasi","year":"1999","journal-title":"Pharmacol Rev"},{"key":"R15-6-20210204","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/j.1432-1033.2004.04082.x","article-title":"Biochemical pharmacology of the vanilloid receptor TRPV1. An update.","volume":"271","author":"Cortright","year":"2004","journal-title":"Eur J Biochem"},{"key":"R20-6-20210204","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/bja\/aer260","article-title":"Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8 patch.","volume":"107","author":"Anand","year":"2011","journal-title":"Br J Anaesth"},{"key":"R21-6-20210204","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF00196108","article-title":"The effectiveness of topically applied capsaicin. A meta-analysis.","volume":"46","author":"Zhang","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"R22-6-20210204","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3959(97)00049-3","article-title":"A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes.","volume":"73","author":"Kingery","year":"1997","journal-title":"Pain"},{"key":"R24-6-20210204","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2165\/11206050-000000000-00000","article-title":"Capsaicin dermal patch: in non-diabetic peripheral neuropathic pain.","volume":"70","author":"McCormack","year":"2010","journal-title":"Drugs"},{"key":"R26-6-20210204","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1212\/01.wnl.0000314647.35825.9c","article-title":"Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"R32-6-20210204","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1517\/13543784.13.11.1445","article-title":"Recent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies.","volume":"13","author":"Bley","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"R36-6-20210204","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/978-3-540-34891-7_29","article-title":"Nociception and TRP channels.","volume":"179","author":"Tominaga","year":"2007","journal-title":"Handb Exp Pharmacol"}],"container-title":["The Clinical Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AJP.0b013e318287a32f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T18:35:34Z","timestamp":1620930934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002508-201402000-00006"}},"subtitle":["Results of a 52-Week Open-Label Study"],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/ajp.0b013e318287a32f","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717995376.793475685","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717995376.793476165","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717995376.793475449","asserted-by":"object"}]},"ISSN":["0749-8047"],"issn-type":[{"value":"0749-8047","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}